TD Cowen analyst Ritu Baral lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $8.50 (from $9.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE